Wednesday, December 6, 2023
Home Tags Ctxr

Tag: ctxr

2023 Watch List

Citius Pharma (CTXR). Reports Fiscal First Quarter 2023 Financial Results and...

Editor / Curator -
2021 Watch List

Report on Citius Pharma (CTXR): North Shore Research Issues a $10...

Editor / Curator -
2021 Watch List

Citius Pharmaceuticals Reports Topline Data from the Pivotal Phase 3 Study...

Editor / Curator -
@NCI
CoronaVirus

Citius (CTXR) Expands Scientific Advisory Board. Dr. John Laffey, Expert in...

Editor / Curator -
Issam Radd
2021 Watch List

Citius (CTXR): Halt For Superiority On The Horizon? (SeekingAlpha).

Editor / Curator -
Biotech Stock Review. Citius, CTXR
Incubator

More Great News From Citius Pharma (CTXR).

Editor / Curator -
Internet Stock Review
2021 Watch List

Stocks On The Move!

Editor / Curator -
CoronaVirus

Citius Pharma (CTXR) Updates Shareholders.

Editor / Curator -
Tiki Hut Fund

Seven of the World’s Top Performing Stocks, Every Morning.

Editor / Curator -
Citius, Leonard Mazur
2020 Watch List

Interview: Citius Pharma (CTXR) $1.74, Chairman Leonard Mazur.

Editor / Curator -
1234Page 1 of 4

Latest article

Hundreds of Stocks Have Fallen Below $1. They’re Still Listed on Nasdaq. (WSJ)

Stand Down Editor / Curator -
Investor-protection advocates say many belong to risky small companies that should be on the OTC market. With 557 names...

Selling Under Cash. LQR House (LQR) Addresses Nasdaq Delisting.

All News Editor / Curator -
If You're a Sophisticated Speculator, and we do Mean Sophisticated, Study LQR House (LQR) or 'the Liquor House' Story.

LQR House (LQR). And the Numbers are In!

All News Editor / Curator -
A Situation Which Can't be Ignored! That's not to say run out and buy it, but this current valuation...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.